Sign In
Buy ABMD
$381.02
+0 (+0%)
At Close: Mar 20, 2023
Why Abiomed Stock Skyrocketed Today
04:49pm, Tuesday, 01'st Nov 2022
A healthcare titan wants to acquire the medical technology specialist for a whopping $16.6 billion.
Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session
04:38pm, Tuesday, 01'st Nov 2022 Benzinga
Gainers
Safe-T Group Ltd (NASDAQ: SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads.
Abiomed, Inc. (NASDAQ: ABMD) shares jumped 50.4%
Dow Drops Over 200 Points; Crude Oil Rises Sharply
04:01pm, Tuesday, 01'st Nov 2022 Benzinga
U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 200 points on Tuesday.
The Dow traded down 0.66% to 32,517.70 while the NASDAQ fell 0.86% to 10,894.04. The S&P 5
Abiomed Shares Pop 50% on Johnson & Johnson Buyout
03:11pm, Tuesday, 01'st Nov 2022
Marking its biggest deal in nearly six years, Johnson & Johnson ( JNJ , Financial) announced on Tuesday it is buying Abiomed Inc. ( ABMD , Financial) for $16.6 billion in a bid to boost its cardiovasc
Abiomed, Inc. (ABMD) Q2 2023 Earnings Call Transcript
03:04pm, Tuesday, 01'st Nov 2022
Abiomed, Inc. (NASDAQ:ABMD ) Q2 2023 Earnings Conference Call November 1, 2022 8:00 AM ET Company Participants Jessica Moore - Vice President of Investor Relations, Johnson & Johnson. Joaquin Duato -
This medical devices stock opened 50% up on Tuesday: here’s why
02:36pm, Tuesday, 01'st Nov 2022 Invezz
ABIOMED Inc (NASDAQ: ABMD) opened about 50% up on Tuesday after Johnson & Johnson (NYSE: JNJ) said it will buy the heart pump maker for $16.6 billion. ABIOMED stock shot up in line with the proposed p
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
02:27pm, Tuesday, 01'st Nov 2022 Benzinga
Upgrades
For AnaptysBio Inc (NASDAQ:ANAB), Guggenheim upgraded the previous rating of Neutral to Buy. AnaptysBio earned $1.15 in the second quarter, compared to $0.02 in the year-ago quarter. The sto
US Stocks Trade Lower Ahead Of Fed Meeting; Pfizer Earnings Top Views
02:21pm, Tuesday, 01'st Nov 2022 Benzinga
U.S. stocks traded lower this morning, with the Dow Jones dropping around 80 points on Tuesday.
Following the market opening Tuesday, the Dow traded down 0.24% to 32,653.67 while the NASDAQ fell 0.24%
J&J Agrees to Buy Heart-Device Maker Abiomed for $16.6 Billion
02:05pm, Tuesday, 01'st Nov 2022
The deal would add heart pumps, a fast-growing part of the medical-device industry, to the J&J lineup.
Judge blocks Penguin-Simon & Schuster deal, Delta pilots call for strike, J&J to buy Abiomed
01:43pm, Tuesday, 01'st Nov 2022
Yahoo Finance anchor Julie Hyman reports the latest headlines including a Judge blocking Penguin-Simon & Schuster deal, Delta pilots calling for strike, J&J planning to buy Abiomed and the Supreme Cou
Uber Rides Higher, but Here's Tuesday's Big Stock Winner
01:11pm, Tuesday, 01'st Nov 2022 The Motley Fool
Earnings are only part of the story.
Abiomed (ABMD) Beats Q2 Earnings Estimates
12:25pm, Tuesday, 01'st Nov 2022 Zacks Investment Research
Abiomed (ABMD) delivered earnings and revenue surprises of 23.81% and 2.70%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Abiomed (ABMD) Q2 Earnings Top Estimates, Margins Down
12:03pm, Tuesday, 01'st Nov 2022
Abiomed's (ABMD) strength in Impella product revenues drives its Q2 top line.
This reliable indicator of recession has yet to buckle, and so the Fed won't either, strategist says
10:56am, Tuesday, 01'st Nov 2022 MarketWatch
A strategist says there's a key element missing before the Fed will pivot.
This medical devices stock opened 50% up on Tuesday: here's why
10:36am, Tuesday, 01'st Nov 2022
ABIOMED Inc (NASDAQ: ABMD) opened about 50% up on Tuesday after Johnson & Johnson (NYSE: JNJ) said it will buy the heart pump maker for $16.6 billion.
